Document

In the course of conducting the business of MariMed Inc. (the “Company”), you may come into possession of material information about the Company or other entities that is not available to the investing public (“material nonpublic information”). You must maintain the confidentiality of material nonpublic information and may not use it in connection with the purchase or sale of Company Securities (defined below) or the securities of any other entity to which the information relates nor may you disclose such information to others except in the limited circumstances set forth below. The Company has adopted this Policy on Insider Trading and Disclosure of Material Nonpublic Information (this “Policy”) in order to ensure compliance with the law and to avoid even the appearance of improper conduct by anyone associated with the Company. We have all worked hard to establish the Company’s reputation for integrity and ethical conduct, and we are all responsible for preserving and enhancing this reputation.

The restrictions set forth in this Policy apply to all Company officers, directors and employees, wherever located, and to their spouses, minor children, adult family members sharing the same household and any other person over whom the officer, director or employee exercises substantial control over his, her or its securities trading decisions. This Policy also applies to any trust or other estate in which an officer, director or employee has a substantial beneficial interest or as to which he or she serves as trustee or in a similar fiduciary capacity.

To avoid even the appearance of impropriety, additional restrictions on trading Company securities (including equity securities, convertible securities, options, bonds, and derivatives thereon) (“Company Securities”) apply to directors, officers and certain designated employees of the Company who have access to material nonpublic information about the Company. These policies are set forth in the Company's Addendum to this Policy (the “Addendum”) that applies to directors, officers, and certain designated employees of the Company who have access to material nonpublic information about the Company. The Company will notify you if you are subject to the Addendum. The Addendum generally prohibits those covered by it from trading in Company Securities during blackout periods, and requires pre-clearance for all transactions in Company Securities.

This Policy and the laws of the United States and many other countries strictly prohibit any director, officer or employee of the Company, from trading Company Securities while in possession of “inside information” about the Company. Inside information is any material nonpublic information about a company.

If you become aware of any inside information, you may not execute any trade in Company Securities and you should treat the information as strictly confidential and, generally, not to be disclosed to others (see “Tipping” below). This prohibition applies to Company Securities as well as the securities of any other company about which you acquire inside information in the course of your duties for the Company. It also applies to transactions for any Company account, client account, employee account or account over which you have investment discretion. You are responsible for reviewing this Policy and ensuring that your actions do not violate it.

Information may be material even if it relates to future, speculative or contingent events and even if it is significant only when considered in combination with publicly available information. Material information can be positive or negative. Nonpublic information can be material even with respect to companies that do not have publicly traded stock, such as those with outstanding bonds or bank loans.

Information is considered to be nonpublic unless it has been adequately disclosed to the public, which means that the information must be publicly disseminated and sufficient time must have passed for the securities markets to digest the information.

It is important to note that information is not necessarily public merely because it has been discussed in the press, which will sometimes report rumors. You should presume that information is nonpublic unless you can point to its official release by the Company in at least one of the following ways:

You may not attempt to “beat the market” by trading simultaneously with, or shortly after, the official release of material information. Although there is no fixed period for how long it takes the market to absorb information, out of prudence a person aware of material nonpublic information should refrain from any trading activity for at least two full trading days following its official release; shorter or longer waiting periods might be warranted based upon the liquidity of the security and the nature of the information.

Notwithstanding these timing guidelines, it is illegal for you to trade while in possession of material nonpublic information, including situations in which you are aware of major developments that have not yet been publicly announced by the Company.

Stock Option Plans. The trading restrictions in this Policy do not apply to exercises of stock options where no Company common stock is sold in the market to fund the option exercise price or related taxes. The trading restrictions do apply, however, to sales of Company common stock received upon the exercise of options in which the

If securities transactions ever become the subject of scrutiny, they are likely to be viewed after-the-fact with the benefit of hindsight. As a result, before engaging in any transaction you should carefully consider how the transaction may be construed in the bright light of hindsight. If you have any questions or uncertainties about this Policy or a proposed transaction, please ask our Chief Financial Officer, Jon R. Levine (the “Compliance Officer”).

In addition to trading while in possession of material nonpublic information, it is illegal and a violation of this Policy to convey such information to another (“tipping”) if you know or have reason to believe that the person will misuse such information by trading in securities or passing such information to others who trade. This applies regardless of whether the "tippee" is related to the insider or is an entity, such as a trust or a corporation, and regardless of whether you receive any monetary benefit from the tippee.

Those subject to this Policy may not trade in options, warrants, puts and calls or similar instruments on Company Securities or sell Company Securities “short”. Investing in Company Securities provides an opportunity to share in the future growth of the Company. Investment in the Company and sharing in the growth of the Company, however, does not mean short-range speculation based on fluctuations in the market. Such activities may put the personal gain of the director, officer or employee in conflict with the best interests of the Company and its shareholders. The simultaneous sale through a broker of some or all of the shares acquired through the exercise of an option granted under a Company compensation plan is not considered a short sale, but such activity (i.e., a cashless exercise of options) is considered a trade and is subject to the restrictions discussed in this Policy and other applicable Company policies.

Notwithstanding the prohibition against insider trading, you are permitted to trade in Company Securities regardless of your awareness of inside information if the transaction is made pursuant to a pre-arranged written trading plan that was adopted when you were not in possession of material nonpublic information and that complies with the

requirements of Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (“Rule 10b5-1 Trading Plan”). If you wish to adopt a Rule 10b5-1 Trading Plan you must submit the plan to the Compliance Officer for his approval prior to the adoption of the plan. Rule 10b5-1 Trading Plans may not be adopted when you are in possession of material nonpublic information about the Company. A Rule 10b5-1 Trading Plan may be amended or replaced only during periods when trading is permitted in accordance with this Policy.

If material information relating to the Company or its business has not been disclosed to the general public, such information must be kept in strict confidence and should be discussed only with persons who have a "need to know" the information for a legitimate business purpose. The utmost care and circumspection must be exercised at all times in order to protect the Company's confidential information. The following practices should be followed to help prevent the misuse of confidential information:

•Avoid discussing confidential information on cellular phones, and take great care when discussing such information on speaker phones. Do not discuss such information with relatives or social acquaintances.

•Always put confidential documents away when not in use and, based upon the sensitivity of the material, keep such documents in a locked desk or office. Do not leave documents containing confidential information where they may be seen by persons who do not have a need to know the content of the documents.

•Be aware that the Internet and other external electronic mail carriers are not secure environments for the transmission of confidential information. Use Company-authorized encryption software to protect confidential electronic communications.

•Upon termination of your employment, you must return to the Company all physical (including electronic) copies of confidential information as well as all other material embodied in any physical or electronic form that is based on or derived from such information, without retaining any copies.

Only Company individuals specifically authorized to do so may answer questions about or disclose information concerning the Company. You may find yourself the recipient of questions concerning various activities of the Company. Such inquiries can come from the media, securities analysts and others regarding the Company's business, rumors, trading activity, current and future prospects and plans, acquisition or divestiture activities and other similar important information. Under no circumstances should you attempt to handle these inquiries without prior authorization. All requests for information regarding the Company should be referred to the Compliance Officer.

you should not share it with anyone. To seek advice about what to do under those circumstances, you should contact the Compliance Officer. Consulting your colleagues can have the effect of exacerbating the problem. Containment of the information, until the legal implications of possessing it are determined, is critical.

In the United States and many other countries, the personal consequences to you of illegally trading securities while in possession of material nonpublic information can be quite severe. Besides requiring disgorgement of profits gained or losses avoided, there are now substantial civil and criminal penalties which may be assessed for insider trading. Penalties could include imposition of a penalty of up to three times the illicit windfall. In addition, corporations may be fined up to $25,000,000 and individuals may be fined up to $5,000,000 and imprisoned for up to twenty years for insider trading violations. Subject to applicable law, Company employees who violate this Policy may also be subject to discipline by the Company, up to and including termination of employment, even if the country or jurisdiction where the conduct took place does not regard it as illegal.

If you are located or engaged in dealings outside the U.S., be aware that laws regarding insider trading and similar offenses differ from country to country. Employees must abide by the laws in the country where located. However, you are required to

All directors, officers and other employees subject to the procedures set forth in this Policy must acknowledge their understanding of, and intent to comply with, this Policy on the form attached to this Policy.

I have received and read the MariMed Inc. Policy on Insider Trading and Disclosure of Material Nonpublic Information (the “Policy”) and I understand its content. I agree to comply fully with the policies and procedures contained in the Policy. If I am an employee of the Company, I acknowledge that the Policy is a statement of policies and procedures and do not, in any way, constitute an employment contract or an assurance of continued employment.

This Addendum to the MariMed Inc. (the “Company”) Policy on Insider Trading and Disclosure of Material Nonpublic Information (the “Policy”) explains requirements and procedures which apply to all directors, officers and certain designated employees of the Company who have access to material nonpublic information about the Company, and is in addition to and supplements the Policy (this “Addendum”). The Company will from time to time designate the individuals who, or positions that, are subject to this Addendum. Please note that this Addendum applies to all Company Securities which you hold or may acquire in the future. Capitalized terms used but not defined in this Addendum shall have the same meaning as set forth in the Policy.

Please read this Addendum carefully. When you have completed your review, please sign the attached acknowledgment form and return it to the Compliance Officer. If you have provided the acknowledgement form attached to this Addendum you do not need to provide the acknowledgment form attached to the Policy.

•Buying or selling Company Securities while in possession of material nonpublic information. In order to avoid even the appearance of impropriety, the Company's policy is to require pre-clearance of all transactions in Company Securities by those subject to this Addendum (as described in more detail below), and to prohibit any transactions in the Company's Securities by those subject to this Addendum during certain designated blackout periods, as detailed below.

•Disclosing material nonpublic information to outsiders, including Family Members (defined below) and others (tipping), who then trade in the Company's Securities or the securities of another company while in possession of that information.

•Retaining "short-swing profits" earned by directors or certain officers through trading in Company Securities, whether or not in possession of material nonpublic information. Any such profits, which generally involve a purchase and sale or a sale and purchase (or any number of these transactions) within any period of less than six months, must be disgorged to the Company.

•The sale of any Company Securities without complying with all the requirements of Rule 144 under the Securities Act of 1933, as amended (the “Securities Act”). Rule 144, also described in more detail later in this Addendum, has detailed reporting requirements (on Form 144), and strict limitations and requirements regarding:

In addition, as a member of the Company’s Board of Directors (“Director”) and/ or as an officer designated by the Company’s Board of Directors as a “Section 16 Officer” you are required to file a number of forms with the Securities and Exchange Commission (the “SEC”) in connection with various events described in Reporting and Form Filing Requirements, below.

Those subject to this Addendum, and their spouses, minor children, adult family members sharing the same household, and any other person over whom the individual exercises substantial control over his, her or its securities trading decisions (collectively, “Family Members”), may not engage in any transaction involving Company Securities (including the exercise of stock options, gifts, loans, contributions to a trust, or any other transfers) without first obtaining pre-clearance of the transaction from the Compliance Officer. Notwithstanding the foregoing, pre-clearance is not required for any trades made

pursuant to a pre-arranged Rule 10b5-1 Trading Plan adopted in accordance with the requirements of the Policy. Each proposed transaction will be evaluated to determine if it raises insider trading concerns or other concerns under federal laws and regulations. Any advice will relate solely to the restraints imposed by law and will not constitute advice regarding the investment aspects of any transaction. Clearance of a transaction is valid only for a 48-hour period. If the transaction order is not placed within that 48-hour period, clearance of the transaction must be re-requested. If clearance is denied, the fact of such denial must be kept confidential by the person requesting such clearance.

In addition to being subject to the limitations set forth in the Policy, you and your Family Members are subject to the following blackout periods, during which no trading in Company Securities will be permitted (except by means of pre-arranged Rule 10b5-1 Trading Plans established in compliance with the Policy).

Quarterly Blackout. Because the announcement of the Company's quarterly financial results will almost always have the potential to have a material effect on the market for Company Securities, you may not trade in the Company Securities during the period beginning on the fifteenth (15th) day prior to the end of the quarter and ending after the second (2nd) trading day following the release of the Company's earnings for that quarter.

Interim Earnings Guidance and Event-Specific Blackouts. The Company may on occasion issue interim earnings guidance or other potentially material information by means of a press release, SEC filing on Form 8-K or other means designed to achieve widespread dissemination of the information. You should anticipate that trading will be blacked out while the Company is in the process of assembling the information to be released and until the information has been released and fully absorbed by the market.

From time to time, an event may occur that is material to the Company and is known by only a few directors or officers. The existence of an event-specific blackout will not be announced. If, however, a person whose trades are subject to pre-clearance requests permission to trade in Company Securities during an event-specific blackout, the Compliance Officer will inform the requesting person of the existence of a blackout period, without disclosing the reason for the blackout. Any person made aware of the existence of an event-specific blackout should not disclose the existence of the blackout to any other person.

You may also be subject to event-specific blackouts pursuant to the SEC's Regulation Blackout Trading Restriction, which prohibits certain sales and other transfers by insiders during certain pension plan blackout periods.

Under Section 16(a) of the Securities Exchange Act of 1934 (the "Exchange Act"), a person who becomes a Director or a Section 16 Officer must file forms with the SEC when he/she engages in transactions involving Company Securities.

Form 3: Initial Beneficial Ownership Statement. A person who becomes a Director or a Section 16 Officer must file a Form 3 within ten days of becoming a Director or Section 16 Officer, even if such person is not an owner of Company Securities at the time. The Form 3 must disclose such person’s ownership of any Company Securities immediately prior to assuming office.

Form 4: Changes of Beneficial Ownership Statement. As long as a person remains a Director or Section 16 Officer, and for up to six months after a person no longer holds such a position with the Company, a Form 4 must be filed before 10:00 p.m. on the second business day following the day that there is a change in the number of Company Securities held from that previously reported to the SEC. There are exceptions to this requirement for gifts and a very limited class of employee benefit plan transactions.

Form 5: Annual Beneficial Ownership Statement. A Form 5 must be filed with the SEC by any individual who served as a Director or Section 16 Officer during any part of the Company's fiscal year to report: (1) all reportable transactions in Company Securities exempt from the Form 4 filing requirement or unreported transactions of less than $10,000; (2) all transactions that should have been reported during the last fiscal year but were not; and (3) with respect to an individual's first Form 5, all transactions which should have been reported but were not for the last two fiscal years.

A Form 5 need not be filed if all transactions otherwise reportable have been previously reported. If required, Form 5 must be filed within 45 days after the end of the Company's fiscal year, which is February 14, or the first business day thereafter. Common types of transactions reportable on Form 5 include gifts and unreported transactions of less than $10,000.

Directors and Section 16 Officers are presumed to beneficially own securities held by Family Members. As a result, Directors and Section 16 Officers must report all holdings and transactions by Family Members.

asked of the Compliance Officer, or, if you prefer, your individual legal counsel. The Company must disclose in its Annual Report on Form 10-K and in its Proxy Statement any delinquent filings of Forms 3, 4 or 5 by Directors and Section 16 Officers, and must post on its website, by the end of the business day after filing with the SEC, any Forms 3, 4 and 5 relating to Company Securities.

Rule 16b-3 under the Exchange Act provides exemptions for Director and Section 16 Officers reporting of certain employee benefit plan events on Forms 4 and 5, including certain routine non-volitional transactions under tax-conditioned thrift, stock purchase and excess benefit plans.

A transaction that results only in a change in the form of a person's beneficial ownership is also exempt from reporting. An exempt "change in the form of beneficial ownership" would include, for example, a distribution of benefit plan securities to an insider participant where the securities were previously attributable to the insider. Exercises or conversions of derivative securities would not, however, be considered mere changes in beneficial ownership and would be reportable.

In order to discourage Directors and Section 16 Officers from profiting through short-term trading transactions in Company Securities, Section 16(b) of the Exchange Act requires that any "short-swing profits" be disgorged to the Company. (This is in addition to the Form reporting requirements described above.)

"Short-swing profits" are profits that result from any purchase and sale, or sale and purchase of the Company's equity securities within a six-month period, unless there is an applicable exemption for either transaction. It is important to note that this rule applies to any matched transactions in the Company's securities (including derivative securities), not only a purchase and sale or sale and purchase of the same shares, or even of the same class of securities. Furthermore, pursuant to the SEC's rules, profit is determined so as to maximize the amount that the Director or Section 16 Officer must disgorge, and this amount may not be offset by any losses realized. "Short-swing profits" may exceed economic profits.

As indicated, to come within the short-swing rules, a purchase and sale (or sale and purchase) within any period of less than six months are matched to determine what profit there is (if any). Rule 16b-3 has carved out a few exceptions to what constitutes a "purchase" for these matching purposes.

Under this Rule certain transactions involving acquisitions of equity securities under employee benefit plans are not counted as "purchases" for short-swing purposes, provided that the benefit plan meets various statutory requirements.

Directors and Section 16 Officers are prohibited from making "short sales" of Company Securities. A short sale has occurred if the seller: (1) does not own the securities sold; or (2) does own the securities sold, but does not deliver them within 20 days or place them in the mail within 5 days of the sale.

Under the Securities Act, affiliates (including officers, Directors and beneficial owners of greater than 10% of Company Securities registered under the Exchange Act) of the Company (“Affiliates”) who wish to sell Company securities generally must comply with the requirements of Rule 144 or be forced to register them under the Securities Act. "Securities" under Rule 144 (unlike under Section 16) are broadly defined to include all securities, not just equity securities. Therefore, the Rule 144 requirements apply not only to common and preferred stock, but also to bonds, debentures and any other form of security. Also, the safe harbor afforded by this rule is available whether or not the securities to be resold were previously registered under the Securities Act (except that the minimum holding period required to satisfy the safe harbor shall apply only to securities which were not registered under the Securities Act).

1.Current public information. There must be adequate current public information available regarding the Company. This requirement is satisfied only if the Company has filed all reports required by the Exchange Act during the twelve months preceding the sale.

2.Manner of sale. The sale of Company Securities must be made in an open market transaction through a broker at the prevailing market price for no more than the usual and customary brokerage commission (or to a market maker at the price held out by the market maker). Furthermore, the broker may not solicit or arrange for the solicitation of customers to purchase the shares. In addition, your

4.Notice of proposed sale. If the amount of Company Securities proposed to be sold during any three-month period exceeds 5,000 shares or has an aggregate sale price in excess of $50,000, a notice of sale must be filed with the SEC on Form 144 prior to, or concurrently with, the placing of the order to sell securities.

5.Holding Periods. Any Company Securities acquired directly or indirectly from the Company in a transaction that was not registered with the SEC under the Securities Act (restricted securities) must be held for six months prior to reselling such securities. There is no statutory minimum holding period for securities which were registered under the Securities Act or acquired in an open-market transaction.

In certain situations (e.g., securities acquired through stock dividends, splits or conversions), "tacking" is permitted, that is, the new securities will be deemed to have been acquired at the same time as the original securities.

The seriousness of securities law violations is reflected in the penalties such violations carry. A Director's resignation may be sought, or an officer will be subject to possible Company disciplinary action up to and including termination of employment. In addition, both the Company itself and individual Directors, officers or employees may be subjected to both criminal and civil liability. These violations may also create negative publicity for the Company.

Because of the technical nature of some aspects of the federal securities laws, you should review this material carefully and contact the Compliance Officer prior to engaging in any transaction in Company Securities which might be in conflict with the securities law and this Addendum and the Policy.

All Directors, officers and certain designated employees of the Company subject to this Addendum must acknowledge their understanding of, and intent to comply with, the Policy and this Addendum on the form attached to this Addendum.

I have received and read the MariMed Inc. Policy on Insider Trading and Disclosure of Material Nonpublic Information (the “Policy”) and this Addendum to the Policy applicable to officers, directors and certain designated employees, and I understand their contents. I agree to comply fully with the policies and procedures contained in the Policy and this Addendum. If I am an employee of the Company, I acknowledge that the Policy and this Addendum are statements of policies and procedures and do not, in any way, constitute an employment contract or an assurance of continued employment.